E-mail page   |     Print page   

 

   

The CDC recommends that screening for hepatitis B be conducted on all communities where the expected prevalence rate of hepatitis B is greater than 2%, or more than twice the rate found in the general population. B Free NYC has developed a comprehensive model program to address health disparities in the African, Afro-Caribbean, Eastern European, and Latino populations.

Hepatitis B and the Latino Community

While there is little information about the prevalence of hepatitis B in the Latino community in NYC, high rates have been reported in other inner-city Hispanic neighborhoods. Because of the high rates of infection reported in several of countries that make-up a large part of the Latino community in NYC, such as Ecuador, Peru, and the Dominican Republic, it is likely that the rates are high in these populations. Persons born in these countries should be screened for hepatitis B. The B-free NYC campaign is working to understand the epidemiology of HBV in the Latino community in NYC to provide better information and guidance about this problem.

 

Hepatitis B and African Americans

Black Americans have a higher rate of chronic HBV than Caucasians. The prevalence of hepatitis B in the U.S.-born black population, particularly in young black males, is higher than the general U.S. population. Rates among Haitians and those of Caribbean descent are 2 to 5 times greater than the general U.S.-born population. The rate is especially high, between 7 to 25 percent, in recent immigrants from sub-Saharan Africa. Chronic hepatitis B is the leading cause of end stage liver disease and hepatocellular carcinoma in Africa. There are more than 90,000 African immigrants living in NYC. While little epidemiological data about the prevalence of HBV in African immigrants in NYC or the U.S. exists, extrapolation from the data from Sub-Saharan Africa suggests that it is likely that this immigrant population has high prevalence rates and should be tested for chronic hepatitis B infection. The B-free NYC campaign is working to understand the epidemiology of HBV in the African community in NYC to provide better information and guidance about this problem.

 

Hepatitis B and Eastern Europeans

Hepatitis B infection is endemic in Eastern Europe with prevalence rates as high as 7% and 8% in such countries as Russia, the Ukraine, Poland, Romania and Bulgaria. Depending on the particular country or area within each country, the exact rate may vary significantly. Although there are no studies of the prevalence of Hepatitis B in Eastern European immigrants in NYC, if you were born in any of these countries you should be tested for chronic HBV infection. The B-free NYC campaign is working to understand the epidemiology of HBV in the Eastern European community in NYC to provide better information and guidance about this problem.  

Community screening events have ended for 2007. To schedule individual screening appointments please contact our partners.

 

BFreeNYC News

Information for Providers

Funded by

the City of New York

 "The New York City Council has approved funding for a 4th year. Through this funding the AAHBP program has been expanded to other populations at risk for hepatitis B, including Eastern European, African American, and Latino communities. Due to expansion of the program beyond the Asian American population in NYC, the program name has changed to B-free NYC"


"The NYC Hepatitis B Program has screened over 8,000 New Yorkers and has vaccinated approximately 2000 at-risk individuals since its inception in 2004. "Read more ...